1. Dek overexpression in murine epithelia increases overt esophageal squamous cell carcinoma incidence
   Marie C. Matrka et al, 2018, PLOS Genetics CrossRef
2. DEK Is a Potential Biomarker Associated with Malignant Phenotype in Gastric Cancer Tissues and Plasma
   Kam-Fai Lee et al, 2019, International Journal of Molecular Sciences CrossRef
3. Prognostic role of DEK in human solid tumors: a meta-analysis
   Gang Liu et al, 2017, Oncotarget CrossRef
4. Exosomal DEK removes chemoradiotherapy resistance by triggering quiescence exit of breast cancer stem cells
   Yao-Shun Yang et al, 2022, Oncogene CrossRef
5. PG545 sensitizes ovarian cancer cells to PARP inhibitors through modulation of RAD51-DEK interaction
   Upasana Ray et al, 2023, Oncogene CrossRef
6. A role for intracellular and extracellular DEK in regulating hematopoiesis
   Maegan L. Capitano et al, 2017, Current Opinion in Hematology CrossRef
7. DEK regulates B-cell proliferative capacity and is associated with aggressive disease in low-grade B-cell lymphomas
   Melissa A. Hopper et al, 2024, Blood Cancer Journal CrossRef
8. DEK promoted EMT and angiogenesis through regulating PI3K/AKT/mTOR pathway in triple-negative breast cancer
   Yang Yang et al, 2017, Oncotarget CrossRef
9. Decreased plasma DEK Oncogene Levels Correlate with p16-Negative Disease and Advanced Tumor Stage in a Case–Control Study of Patients with Head and Neck Squamous Cell Carcinoma
   Trisha Wise-Draper et al, 2018, Translational Oncology CrossRef
10. The Art of War: harnessing the epigenome against cancer
    Jonathan Nye et al, 2018, F1000Research CrossRef
11. NUP214 in Leukemia: It’s More than Transport
    Adélia Mendes et al, 2019, Cells CrossRef